|
2011
Press
Release Index
Drug
Screening for Pain Management Medications
Technical
Bulletin
Drug Screens
 Pain
Management
A routine drug screen
uses an opiate cut-off of 2000 ng/ml.
It is designed to detect abusers
and will miss patients taking oxycodone
or other opiates taken as prescribed.
We have a new, low cost urine screen
for checking compliance for commonly
prescribed pain medications. The
panel consists of:
- Opiates
(300ng/ml cut-off)
- Oxycodone
- Methadone
metabolite
- Buprenorphine
This
is a sensitive test that will detect normally prescribed dosages
of pain medication. Results will not automatically be confirmed
by GC/MS. This test was developed at physicians’ request
to provide a cost effective tool for assuring a patient is
taking prescribed pain medication. The test requires a single
urine collection, collected like a routine drug screen. The
test name is PAIN MANAGEMENT PANEL, and the test code is PAIN.
New
Federal Guidelines
Federal Register/ Vol. 75 No. 157/ August 16, 2010/Rules and Regulations:
Urine
drug screens that test for opiates must include 6-acetlymorphine
(abbreviated 6-AM). 6-AM is heroin metabolite. Urine drug
screens that test for amphetamine and methamphetamine must
now include Ecstasy. AMS Lab already includes Ecstasy on its
drug screens, but will add 6-AM. Additional changes in the
rules that have already been implemented at AMS are the screening
and confirmation cut-offs have been lowered for amphetamine,
methamphetamine, MDA, MDMA, MDEA, and cocaine metabolite.
| Top of Page |
|
